Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPA1 | P15085 | 7/20 | 0.57 |
| ▸ | CPA3 | P15088 | 2/20 | 0.57 |
| ▸ | CPB1 | P15086 | 1/20 | 0.57 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.51 |
| ▸ | MME | P08473 | 1/20 | 0.50 |
| ▸ | KMO | O15229 | 1/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.49 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.49 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.49 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.49 |
| ▸ | ANPEP | P15144 | 1/20 | 0.48 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.48 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.48 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27584150 | 0.78 | PTPN1 (0.57) | CYP1A2PTPN1NR4A1NR4A2NR4A3 | |
| SCHEMBL11154852 | 0.77 | PTPN1 (0.56) | CYP1A2PTPN1NR4A1NR4A2NR4A3 | |
| SCHEMBL7352579 | 0.77 | CYP1A2 (0.65) | CPA1CPA3CPB1CPB2CYP1A2 | |
| SCHEMBL10389827 | 0.76 | CPA1 (0.53) | CPA1CPA3CPB1CPB2CYP1A2 | |
| SCHEMBL7320860 | 0.76 | CPA1 (0.53) | CPA1CPA3CPB1CPB2CYP1A2 | |
| SCHEMBL7315538 | 0.76 | TSHR (0.75) | CPA1CPA3CPB1CPB2CYP1A2 | |
| SCHEMBL3104186 | 0.76 | TSHR (0.75) | CPA1CPA3CPB1CPB2CYP1A2 | |
| SCHEMBL3282190 | 0.76 | PTPN1 (0.62) | CYP1A2PTPN1NR4A1NR4A2NR4A3 | |
| SCHEMBL4109693 | 0.74 | PTPN1 (0.61) | CYP1A2PTPN1NR4A1NR4A2NR4A3 | |
| SCHEMBL9000004 | 0.74 | PTPN1 (0.61) | CYP1A2PTPN1NR4A1NR4A2NR4A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050070553-A1 | Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes | MERCK PATENT GMBH (DE) | 2005-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050070553-A1 | Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes | GANAB, GAA, GANC | CPA1 376/4885CPA3 565/4885CPB1 254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.